ARE YOUR COMPANION DIAGNOSTIC PARTNERS READY?

Our CEO Seamus Kearney examines the changes in the new EU IVDR and how these will impact on the availability of precision medicine in the European Union.

Visit our member’s area to download this whitepaper and keep updated of any future articles as they are published.